Anzeige
Mehr »
Freitag, 16.05.2025 - Börsentäglich über 12.000 News
Verpasst du gerade die Buffett-Aktie der neuen Generation?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2DN2N | ISIN: SE0009663826 | Ticker-Symbol: 6MA
Frankfurt
15.05.25 | 09:15
9,690 Euro
-2,91 % -0,290
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
AMBEA AB Chart 1 Jahr
5-Tage-Chart
AMBEA AB 5-Tage-Chart
RealtimeGeldBriefZeit
9,6509,88015.05.
GlobeNewswire (Europe)
62 Leser
Artikel bewerten:
(0)

Ambea AB: Ambea's interim report January - March 2025

Finanznachrichten News

Entry into Finnish market enables increased Nordic growth

CEO comments:

After the end of the quarter, we completed the acquisition of Validia in Finland, making us the only care provider with a strong presence in the four largest Nordic countries.

The need for qualitative and sustainable care is increasing across the Nordic region. During the quarter, we opened a total of six new care units with a total of 33 care places and signed rental contracts for four additional care units with a total of 15 care places, all in Nytida and Stendi.

Vardaga has signed a contract to increase capacity by 30 beds and decided to open a previously completed nursing home in the third quarter of 2025.

Stendi reported continued stable occupancy and new long-term contracts that contribute to future growth.

Altiden in Denmark is now entering a new phase as the new Elderly Care Reform will become effective on 1 July 2025, opening for more start-up units under own management.

Nytida welcomes the new Social Services Act that will become effective in summer 2025 and is actively preparing to help municipalities in its implementation. After the end of the quarter, we announced an acquisition in Sweden encompassing care units for both Vardaga and Nytida.

Ambea is well positioned to help society with more new care places, and the acquisition of Validia offers us access to a new market with good growth potential. We continue to seek new opportunities for growth in all markets to consistently achieve our annual growth target, while also achieving our other financial targets.

First quarter January - March

  • Net sales rose 5 per cent to SEK 3,644 million (3,484). Organic growth was 4 per cent, acquired/divested growth was 2 per cent, and currency/calendar effect was -1 per cent.
  • Adjusted EBITA, which excludes items affecting comparability, amounted to SEK 307 million (279), representing a margin of 8.4 per cent (8.0).
  • Items affecting comparability amounted to SEK 30 million and refer to transaction costs related to the acquisition of Validia in Finland.
  • EBITA amounted to SEK 277 million (279), representing a margin of 7.6 per cent (8.0).
  • Operating profit (EBIT) totalled SEK 264 million (256), representing a margin of 7.2 per cent (7.3).
  • Profit for the period totalled SEK 116 million (111).
  • Earnings per share amounted to SEK 1.39 (1.25) before dilution and SEK 1.39 (1.25) after dilution.
  • Cash conversion totalled 70.0 per cent (97.8).
  • Free cash flow totalled SEK 262 million (414).

Webcast/telephone conference

In connection to the announcement, Ambea will host a telephone conference today at 10:00 (CET). The presentation will be held in English and available as webcast on www.ambea.com or direct link: https://edge.media-server.com/mmc/p/pcnxrd65/

Telephone conference
To participate in the conference call, register before the call using the link below. Upon registration you will receive a dial-in number and a unique personal PIN code. To ensure that the connection to the conference call is working, please call ten minutes before the conference call is due to start.

Registration:
https://register-conf.media-server.com/register/BId5629c8ab18d4db2b86a56d6cd26a236

The quarterly earnings report and related presentation will be available on https://ambea.com/investor-relations/reports/reports-and-presentations/

This disclosure contains information that Ambea is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014) and the Swedish Securities Markets Act (2007:528). The information was submitted for publication, through the agency of the contact person, on 06-05-2025 07:00 CET.

For more information, contact:

Susanne Vogt, head of IR
E-mail: ir@ambea.se

Ambea media contact
Telephone: +46 (0)10 33 00 501
E-mail: press@ambea.se

Ambea is Scandinavia's leading competence-based care company. Ambea has over 38,000 employees who are creating a good life for more than 16,000 care receivers in our 1,000 units across the Nordics. We aim to be the quality leader in all that we do and our vision is to make the world a better place, one person at a time. Ambeas head office is located in Solna, Sweden. Ambea is listed on Nasdaq Stockholm.

© 2025 GlobeNewswire (Europe)
Die USA haben fertig! 5 Aktien für den China-Boom
Die Finanzwelt ist im Umbruch! Nach Jahren der Dominanz erschüttert Donald Trumps erratische Wirtschaftspolitik das Fundament des amerikanischen Kapitalismus. Handelskriege, Rekordzölle und politische Isolation haben eine Kapitalflucht historischen Ausmaßes ausgelöst.

Milliarden strömen aus den USA – und suchen neue, lukrative Ziele. Und genau hier kommt China ins Spiel. Trotz aller Spannungen wächst die chinesische Wirtschaft dynamisch weiter, Innovation und Digitalisierung treiben die Märkte an.

Im kostenlosen Spezialreport stellen wir Ihnen 5 Aktien aus China vor, die vom US-Niedergang profitieren und das Potenzial haben, den Markt regelrecht zu überflügeln. Wer jetzt klug investiert, sichert sich den Zugang zu den neuen Wachstums-Champions von morgen.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche 5 Aktien die Konkurrenz aus den USA outperformen dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.